-
Before you choose a CRO
– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of Development at Spago Nanomedical says.
-
Analytisk kemi nytt ben för Recipharm
CDMO Recipharm lanserar en fristående tjänst inom analytisk kemi.
-
How to become globally competitive
Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.
-
Dålig rapportering av läkares relation till industrin
Sverige bland de sämsta länderna, visar ny studie.
-
Opinion: Where do all the cool Swedish life science companies go?
It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful ‘startups’ founded in Sweden.
-
Oasmia får ny ordförande
Karo Pharmas ordförande Anders Lönner föreslås även leda Oasmias styrelse i samband med en ny affär mellan bolagen.
-
Rustar inför exit
Synthetic MR får en ny styrelsetopp lagom till avknoppningen från Accelerator.
-
Robotprotes som kan styras med tanken
För första gången har en robotarm som kan styras med tanken opererats fast på en patient.
-
Ny vd på Spago Imaging
Andreas Bunge tar över spakarna i medtech-bolaget.
-
Add Bio får tre nya ägare
Tar in 9,4 miljoner kronor i nyemission.
-
Accelerator får ny vd
Maria Fors tar över spakarna då nuvarande vd:an Andreas Bunge ökar fokus på dotterbolaget Spago.
-
Fäster bättre med behandlad yta
Add Bio visar positiva resultat med tandimplantat i klinik.
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming, e-solutions company for clinical trials, eager to thrive on this development.
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and sourcing of resources.
-
Your partnering tool - step by step
Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!
-
Hallå där Bjarte Reve...
... vd på Oslo Cancer Cluster som just har inlett ett samarbete med ett amerikanskt kluster. Hur och när kommer samarbetet att ge resultat hos era bolag?
-
Multilabel plate readers with luminescence capability
The Enspire Multilabel Plate Reader platform from Perkin Elmer now features sensitive luminescence detection. The new detection capability is primarily aimed at improving assay performance and sensitivity for scientists working with primary cells or stem cells in cancer and neuropharmacology research.
-
Enklare RNA preparering med nytt system
NuGen lanserar Applause, ett nytt system för enklare förberedning av RNA.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
Få tillgång till allt innehåll på Life Science Sweden
Ingen bindningstid eller kortinformation krävs
Redan prenumerant? Logga in
Gäller endast personlig prenumeration.
Kontakta oss för en företagslösning.
BREAKING